Skip Content
You are currently on the new version of our website. Access the old version .

Pharmaceuticals, Volume 8, Issue 2

2015 June - 14 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (14)

  • Article
  • Open Access
6 Citations
6,115 Views
14 Pages

Tryptophan Breakdown in Patients with HCV Infection is Influenced by IL28B Polymorphism

  • Heinz Zoller,
  • Annina Jenal,
  • Albert F. Staettermayer,
  • Sebastian Schroecksnadel,
  • Peter Ferenci and
  • Dietmar Fuchs

18 June 2015

Until recently, the standard treatment of chronic hepatitis C virus (HCV) infection was a combination therapy with PEG-IFN-α plus ribavirin. Previous studies have proven that several markers predict the outcome of such therapy, e.g., pretreatment pla...

  • Article
  • Open Access
28 Citations
8,685 Views
15 Pages

18 June 2015

We investigated the effect of a formula containing two different prebiotics (bifidogenic growth stimulator and galacto-oligosaccharide) and fermented milk products on intestinal microbiota and antibody responses to an influenza vaccine in enterally f...

  • Review
  • Open Access
211 Citations
14,801 Views
16 Pages

A Critical Review of Alpha Radionuclide Therapy—How to Deal with Recoiling Daughters?

  • Robin M. De Kruijff,
  • Hubert T. Wolterbeek and
  • Antonia G. Denkova

10 June 2015

This review presents an overview of the successes and challenges currently faced in alpha radionuclide therapy. Alpha particles have an advantage in killing tumour cells as compared to beta or gamma radiation due to their short penetration depth and...

  • Review
  • Open Access
50 Citations
11,060 Views
18 Pages

9 June 2015

X-linked dilated cardiomyopathy (XLDCM) is a distinct phenotype of dystrophinopathy characterized by preferential cardiac involvement without any overt skeletal myopathy. XLDCM is caused by mutations of the Duchenne muscular dystrophy (DMD) gene and...

  • Article
  • Open Access
37 Citations
7,925 Views
24 Pages

Synthesis, Biological Evaluation and Molecular Modeling of Substituted Indeno[1,2-b]indoles as Inhibitors of Human Protein Kinase CK2

  • Faten Alchab,
  • Laurent Ettouati,
  • Zouhair Bouaziz,
  • Andre Bollacke,
  • Jean-Guy Delcros,
  • Christoph G.W. Gertzen,
  • Holger Gohlke,
  • Noël Pinaud,
  • Mathieu Marchivie and
  • Marc Le Borgne
  • + 3 authors

8 June 2015

Due to their system of annulated 6-5-5-6-membered rings, indenoindoles have sparked great interest for the design of ATP-competitive inhibitors of human CK2. In the present study, we prepared twenty-one indeno[1,2-b]indole derivatives, all of which w...

  • Article
  • Open Access
11 Citations
7,967 Views
20 Pages

Microwave-Assisted Synthesis of a MK2 Inhibitor by Suzuki-Miyaura Coupling for Study in Werner Syndrome Cells

  • Mark C. Bagley,
  • Mohammed Baashen,
  • Irina Chuckowree,
  • Jessica E. Dwyer,
  • David Kipling and
  • Terence Davis

3 June 2015

Microwave-assisted Suzuki-Miyaura cross-coupling reactions have been employed towards the synthesis of three different MAPKAPK2 (MK2) inhibitors to study accelerated aging in Werner syndrome (WS) cells, including the cross-coupling of a 2-chloroquino...

  • Review
  • Open Access
15 Citations
6,984 Views
7 Pages

Immunotherapeutic Applications of NK Cells

  • Carter T. Davis and
  • David Rizzieri

25 May 2015

Natural Killer (NK) cells are lymphoid cells that exhibit an innate response against virus-infected cells. These cells are also capable of mounting an immune response against tumor cells after education through major histocompatibility complex (MHC)...

  • Article
  • Open Access
9 Citations
5,156 Views
9 Pages

8 May 2015

Seven novel N-arylsulfonyl-3-(2-yl-ethanone)-6-methylindole derivatives 4af and 6 were readily synthesized and have been identified as inhibitors of human immunodeficiency virus type-1 (HIV-1) replication. Initial biological studies indicated that a...

  • Review
  • Open Access
40 Citations
10,411 Views
20 Pages

Seatbelts in CAR therapy: How Safe Are CARS?

  • Kentaro Minagawa,
  • Xiaoou Zhou,
  • Shin Mineishi and
  • Antonio Di Stasi

8 May 2015

T-cells genetically redirected with a chimeric antigen receptor (CAR) to recognize tumor antigens and kill tumor cells have been infused in several phase 1 clinical trials with success. Due to safety concerns related to on-target/off-tumor effects or...

  • Article
  • Open Access
3 Citations
5,902 Views
10 Pages

Does Amifostine Reduce Metabolic Rate? Effect of the Drug on Gas Exchange and Acute Ventilatory Hypoxic Response in Humans

  • Jaideep J. Pandit,
  • Caroline Allen,
  • Evelyn Little,
  • Federico Formenti,
  • Adrian L. Harris and
  • Peter A. Robbins

16 April 2015

Amifostine is added to chemoradiation regimens in the treatment of many cancers on the basis that, by reducing the metabolic rate, it protects normal cells from toxic effects of therapy. We tested this hypothesis by measuring the metabolic rate (by g...

  • Review
  • Open Access
28 Citations
7,461 Views
25 Pages

16 April 2015

Allogeneic hematopoietic cell transplantation (allo-HCT), a treatment option in hematologic malignancies and bone marrow failure syndromes, is frequently complicated by Graft-versus-host disease (GVHD). The primary treatment for GVHD involves immune...

  • Review
  • Open Access
143 Citations
12,456 Views
25 Pages

Reactive Oxygen Species, Apoptosis, Antimicrobial Peptides and Human Inflammatory Diseases

  • Babatunji Emmanuel Oyinloye,
  • Abiola Fatimah Adenowo and
  • Abidemi Paul Kappo

2 April 2015

Excessive free radical generation, especially reactive oxygen species (ROS) leading to oxidative stress in the biological system, has been implicated in the pathogenesis and pathological conditions associated with diverse human inflammatory diseases...

  • Communication
  • Open Access
20 Citations
7,697 Views
10 Pages

Edaravone Enhances Brain-Derived Neurotrophic Factor Production in the Ischemic Mouse Brain

  • Satoshi Okuyama,
  • Mayu Morita,
  • Atsushi Sawamoto,
  • Tsukasa Terugo,
  • Mitsunari Nakajima and
  • Yoshiko Furukawa

2 April 2015

Edaravone, a clinical drug used to treat strokes, protects against neuronal cell death and memory loss in the ischemic brains of animal models through its antioxidant activity. In the present study, we subcutaneously administrated edaravone to mice...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Pharmaceuticals - ISSN 1424-8247